A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
BerGenBio ASA
Sumitomo Pharma America, Inc.
Celgene
Celgene
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Novartis
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center